Page d'accueil  |  Aide  |  Effacer
Anglais  |  Français
 Rechercher  |  Catégories  |  Titres A-Z  |  Pays  |  Comparer pays  |  Index  
Etendre sommaire
Document complet
Dérouler chapitre
Préférences

fermer ce livreDrugs Formulary for District Hospitals - Ethiopia (DACA; 2004; 322 pages)
Afficher le documentACKNOWLEDGEMENTS
Afficher le documentINTRODUCTION
Afficher le documentGENERAL ADVICE TO PRESCRIBERS
fermer ce répertoire1. DRUGS ACTING ON THE GASTROINTESTINAL SYSTEM
Afficher le document1.1. Antacids
Afficher le document1.2. Anti-ulcer Agents
Afficher le document1.3. Antispasmodics/spasmolytic Analgesics
Afficher le document1.4. Antiemetics
Afficher le document1.5. Cathartics and Laxative
Afficher le document1.6. Agents used in Diarrhea
Afficher le document1.7. Antiflatulants
Afficher le document1.8. Antihaemorrhoidal Agents
ouvrir ce répertoire et afficher son contenu2. CARDIOVASCULAR DRUGS
ouvrir ce répertoire et afficher son contenu3. RESPIRATORY DRUGS
ouvrir ce répertoire et afficher son contenu4. CENTRAL NERVOUS SYSTEM DRUGS
ouvrir ce répertoire et afficher son contenu5. DRUGS USED IN ANESTHESIA
ouvrir ce répertoire et afficher son contenu6. DRUGS USED IN MUSCLOSKELETAL AND JOINT DISEASE
ouvrir ce répertoire et afficher son contenu7. ANTI-INFECTIVE
ouvrir ce répertoire et afficher son contenu8. DRUGS USED IN ENDOCRINE DISORDERS AND CONTRACEPTIVES.
Afficher le document9. OBSTETRIC AND GYNAECOLOGICAL MEDICATIONS
ouvrir ce répertoire et afficher son contenu10. BLOOD PRODUCTS AND DRUGS AFFECTING THE BLOOD
ouvrir ce répertoire et afficher son contenu11. DRUGS FOR CORRECTING WATER, ELECTROLYTE AND ACID - BASE DISTURBANCES
ouvrir ce répertoire et afficher son contenu12. VITAMINS
ouvrir ce répertoire et afficher son contenu13. ANTIHISTAMINES AND ANTIALLERGICS
ouvrir ce répertoire et afficher son contenu14. OPHTHALMIC AGENTS
ouvrir ce répertoire et afficher son contenu15. EAR, NOSE, AND THROAT PREPARATIONS
ouvrir ce répertoire et afficher son contenu16. DERMATOLOGIC AGENTS
Afficher le document17. ANTIDOTES AND OTHER SUBSTANCES USED IN POISONING
Afficher le document18. IMMUNOLOGICAL PREPARATIONS
Afficher le document19. MISCELLANEOUS
Afficher le documentAPPENDIXES
Afficher le documentGLOSSARY
Afficher le documentBACK COVER
 

1.8. Antihaemorrhoidal Agents

Haemorrhoids are enlarged or varicose veins of the tissues at the anus or rectal outlet. They are the most frequent cause of rectal bleeding. Anal and perianal pruritus, soreness and excoriation occur commonly in patient suffering from haemorrhoids, fistulas and proctitis. Careful local toilet with attention to any minor, faecal soiling, adjustment of the diet to avoid hard stools, the use of bulk forming materials such as bran and a high residue diet are helpful.

Soothing preparations containing mild astringents such as bismuth subgallate, Zinc oxide, peru balsam and hamamelis with lubricants, vasoconstrictors or mild antiseptics, in the form of topical ointments, creams and suppositories, are used to provide symptomatic relief. Local anesthetics may be included to relieve pain, and corticosteroids may be used when infection is not present; preparations containing either group of drugs are intended only for short term use after exclusion of infections, such as herpes simplex; prolonged use can cause atrophy of the anal skin.

Haemorrhoids in children are rare. Treatment is usually symptomatic and the use of locally applied cream is appropriate for short periods; however, local anaesthetics can cause stinging initially and this may aggravate the child's fear of defecation.

Bismuth Subgallate Compound (Bismuth Subgallate + Bismuth Oxide +Peru Balsam + Zinc Oxide)3
Ointment, 2.25% + 0.87% + 1.875% + 10.75%
Suppository, 59mg + 24mg + 49mg + 296mg

3 Any antihaemorrhoidal preparation proven to be therapeutically effective can be used.


Indications: - to relieve anal and perianal pain, itching and soreness associated with hemorrhoids, anal fissures.

Cautions:- advise patients to regulate their diet to produce soft stools that pass through the anus with a minimum irritation. Patients should be instructed to take hygienic measures after defecation. See also notes above.

Dose and Administration: Rectally, wash and dry the anal area before application.

Unless otherwise indicated; Ointment - Apply rectally night and morning and after defecation. Suppositories - Insert in to the rectum night and morning and after defection.

Storage: - in a cool place.

Bismuth Subgallate Compound With Hydrocortisone (Bismuth Subgallate + Bismuth Oxide + Peru Balsam + Zinc Oxide + Hydrocortisone acetate + Benzyl Benzoate)3
Ointment, 2.25% + 0.875% + 1.875% +10.75% + 0.25% +1.25%
Suppository, 59mg + 24mg + 49mg +296mg + 10mg + 33mg

3 Any antihaemorrhoidal preparation proven to be therapeutically effective can be used.


Indications: - same as Bismuth Subgallate Compound, and anal inflammation in the absence of infection, see notes above.

Cautions: Same as Bismuth Subgallate Compound. Avoid this preparation in the presence of an infection in the rectal area.

Contraindications: - known hypersensitivity to the preparation, untreated infection.

Side effects: worsening of untreated infection, and thinning of the skin structure on prolonged use.

Dose and Administration: Rectally. Wash and dry the rectal area before application.

Unless otherwise indicated, Ointments - Apply rectally night and morning and after defection. Suppositories - Insert into the rectum night and morning and after defection.

Storage: in a cool place.

Lidocaine + Aluminium Acetate + Zinc Oxide + Hydrocortisone Acetate3
Ointment, 50 mg + 35 mg + 180 mg + 2.5 mg
Suppository, 60 mg + 50 mg + 500 mg + 5 mg.

3 Any antihaemorrhoidal preparation proven to be therapeutically effective can be used.


Indications: - for treatment of hemorrhoids. They are suitable for occasional short-term use after exclusion of infection, such as herpes simplex

Dose and Administration: - Ointment - Apply several times daily, short - term use; Suppositories - insert 1 suppository at night and after a bowel movement; short-term use only.

Prednisolone Caproate + Dibucaine Hydrochloride + Hexachlorophene + Clemizole undecenoate3
Ointment, 0.19 % + 0.5 % + 0.5 % + 0.5 % + 1 %
Suppository, 1.3 mg + 1 mg + 2.5 mg + 5 mg.

3 Any antihaemorrhoidal preparation proven to be therapeutically effective can be used.


Indications: - short term Symptomatic treatment of hemorrhoids.

vers la section précédentevers la section suivante

S'il vous plaît envoyez vos commentaires Anglais  |  Français